Stockscreener 앱 받기
13.44
2.82%
-0.39
전일 마감가:
$13.83
열려 있는:
$13.63
하루 거래량:
1.76M
Relative Volume:
1.18
시가총액:
$1.95B
수익:
$340.81M
순이익/손실:
$-419.65M
주가수익비율:
-4.7158
EPS:
-2.85
순현금흐름:
$-402.10M
1주 성능:
-1.68%
1개월 성능:
-3.66%
6개월 성능:
-42.32%
1년 성능:
-42.39%
1일 변동 폭
$13.25
$14.02
1주일 범위
$13.25
$14.71
52주 변동 폭
$10.57
$33.33
Denali Therapeutics Inc Stock (DNLI) Company Profile
명칭
Denali Therapeutics Inc
전화
(650) 866-8547
주소
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
DNLI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DNLI
Denali Therapeutics Inc
|
13.44 | 2.01B | 340.81M | -419.65M | -402.10M | -2.85 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2025-03-07 | 재개 | Morgan Stanley | Overweight |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2025-01-07 | 개시 | Robert W. Baird | Outperform |
| 2025-01-03 | 개시 | William Blair | Outperform |
| 2024-12-16 | 업그레이드 | Stifel | Hold → Buy |
| 2024-10-10 | 재개 | Raymond James | Mkt Perform |
| 2024-10-07 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-12-13 | 개시 | Citigroup | Buy |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-10-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2023-09-06 | 개시 | B. Riley Securities | Buy |
| 2023-01-30 | 개시 | SVB Securities | Outperform |
| 2022-12-05 | 개시 | Cowen | Outperform |
| 2022-11-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-02 | 개시 | BofA Securities | Buy |
| 2022-06-23 | 개시 | Berenberg | Buy |
| 2021-12-10 | 재개 | Raymond James | Mkt Perform |
| 2021-09-21 | 개시 | Oppenheimer | Outperform |
| 2021-09-01 | 개시 | SMBC Nikko | Outperform |
| 2021-05-18 | 개시 | UBS | Buy |
| 2021-02-26 | 재확인 | H.C. Wainwright | Buy |
| 2021-02-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-11-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-09-14 | 재개 | JP Morgan | Overweight |
| 2020-08-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-02-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2020-02-24 | 개시 | Jefferies | Buy |
| 2020-02-19 | 개시 | Stifel | Hold |
| 2020-01-27 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-09-26 | 개시 | Wedbush | Neutral |
| 2019-09-13 | 개시 | Nomura | Buy |
| 2019-08-09 | 개시 | BTIG Research | Buy |
| 2019-06-26 | 개시 | H.C. Wainwright | Buy |
| 2018-11-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 개시 | Janney | Buy |
| 2018-03-12 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2018-01-02 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 개시 | Goldman | Neutral |
| 2018-01-02 | 개시 | JP Morgan | Overweight |
| 2018-01-02 | 개시 | Morgan Stanley | Overweight |
모두보기
Denali Therapeutics Inc 주식(DNLI)의 최신 뉴스
Does Denali Therapeutics Inc. stock perform well during market downturnsPost Market Picks With Low Risk - jammulinksnews.com
Denali Therapeutics Inc. (DNLI) Secures FDA Priority Review for First-Ever Brain-Penetrant Hunter Syndrome Therapy - Insider Monkey
What makes Denali Therapeutics Inc. stock price move sharplyTop Growth Planner For Every Investor - jammulinksnews.com
What is Denali Therapeutics Inc. company’s growth strategyFree Stock Insights For Every Investor - jammulinksnews.com
Price momentum metrics for Denali Therapeutics Inc. explainedStock Portfolio Allocation Guidance for Volatile Markets - metal.it
11 Best Future Stocks to Buy Now - Insider Monkey
Biogen’s BIIB122 Study: A New Hope for LRRK2-Associated Parkinson’s Disease - TipRanks
Can Denali Therapeutics Inc. Rally Enough to Break EvenReal Profit Trade Plan Suggestions Shared Widely - metal.it
Is Denali Therapeutics Inc. a growth stock or a value stockBest Dividend Data Feed Backed By Experts - jammulinksnews.com
Volume Surge May Signal Institutional Interest in Denali Therapeutics Inc.Trade Setups With Clear Risk Limits Highlighted - metal.it
What are analysts’ price targets for Denali Therapeutics Inc. in the next 12 monthsMaximize returns with expert trading insights - jammulinksnews.com
How volatile is Denali Therapeutics Inc. stock compared to the marketGet exclusive market analysis for investors - jammulinksnews.com
Is it the right time to buy Denali Therapeutics Inc. stockAccess powerful market insights for free - jammulinksnews.com
What are the technical indicators suggesting about Denali Therapeutics Inc.Real Time Guidance For 2025 - jammulinksnews.com
How does Denali Therapeutics Inc. generate profit in a changing economyUnlock powerful stock screening tools today - jammulinksnews.com
Published on: 2025-07-28 03:16:35 - jammulinksnews.com
Is Denali Therapeutics Inc. stock overvalued or undervaluedMaximize gains with data-driven stock picks - jammulinksnews.com
What is the risk reward ratio of investing in Denali Therapeutics Inc. stockBoost your returns with professional guidance - jammulinksnews.com
How strong is Denali Therapeutics Inc. company’s balance sheetCapitalize on market momentum for maximum profit - jammulinksnews.com
Published on: 2025-07-27 16:21:55 - jammulinksnews.com
BTIG Reiterates a Buy Rating on Denali Therapeutics (DNLI) With a $32 Price Target - MSN
What drives Denali Therapeutics Inc. stock priceRapid growth opportunities - PrintWeekIndia
Why Denali Therapeutics Inc. stock is on top investor watchlistsStrongest growth potential - jammulinksnews.com
Will Denali Therapeutics Inc. stock benefit from interest rate changesFree Investment Community - jammulinksnews.com
What analysts say about Denali Therapeutics Inc. stockOutstanding capital growth - Autocar Professional
Is Denali Therapeutics Inc. a good long term investmentOutperformance with explosive growth - jammulinksnews.com
Denali Therapeutics Inc. Stock Analysis and ForecastRapidly expanding wealth - jammulinksnews.com
Denali Therapeutics Inc (DNLI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Denali Therapeutics Inc 주식 (DNLI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. | President and CEO |
Jul 09 '25 |
Sale |
15.00 |
495,282 |
7,429,230 |
253,071 |
0.93%
0.15%
자본화:
|
볼륨(24시간):